Helen J Burgess1, Margaret Park2, James K Wyatt2, Muneer Rizvydeen3, Louis F Fogg4. 1. Biological Rhythms Research Laboratory, Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA. Electronic address: Helen_J_Burgess@rush.edu. 2. Section of Sleep Disorders and Sleep-Wake Research, Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA. 3. Biological Rhythms Research Laboratory, Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA. 4. College of Nursing, Rush University Medical Center, Chicago, IL, USA.
Abstract
OBJECTIVE/ BACKGROUND: To compare sleep and circadian variability in adults with delayed sleep-wake phase disorder (DSWPD) to healthy controls. PATIENTS/ METHODS: Forty participants (22 DSWPD, 18 healthy controls) completed a ten-day protocol, consisting of DLMO assessments on two consecutive nights, a five-day study break, followed by two more DLMO assessments. All participants were instructed to sleep within one hour of their self-reported average sleep schedule for the last four days of the study break. We analyzed the participants' wrist actigraphy data during these four days to examine intraindividual variability in sleep timing, duration and efficiency. We also examined shifts in the DLMO from before and after the study break. RESULTS AND CONCLUSIONS: Under the same conditions, people with DSWPD had significantly more variable wake times and total sleep time than healthy controls (p ≤ 0.015). Intraindividual variability in sleep onset time and sleep efficiency was similar between the two groups (p ≥ 0.30). The DLMO was relatively stable across the study break, with only 11% of controls but 27% of DSWPDs showed more than a one hour shift in the DLMO. Only in the DSWPD sample was greater sleep variability associated with a larger shift in the DLMO (r = 0.46, p = 0.03). These results suggest that intraindividual variability in sleep can be higher in DSWPD versus healthy controls, and this may impact variability in the DLMO. DSWPD patients with higher intraindividual variability in sleep are more likely to have a shifting DLMO, which could impact sleep symptoms and the optimal timing of light and/or melatonin treatment for DSWPD. CLINICAL TRIAL: Circadian Phase Assessments at Home, http://clinicaltrials.gov/show/NCT01487252, NCT01487252.
OBJECTIVE/ BACKGROUND: To compare sleep and circadian variability in adults with delayed sleep-wake phase disorder (DSWPD) to healthy controls. PATIENTS/ METHODS: Forty participants (22 DSWPD, 18 healthy controls) completed a ten-day protocol, consisting of DLMO assessments on two consecutive nights, a five-day study break, followed by two more DLMO assessments. All participants were instructed to sleep within one hour of their self-reported average sleep schedule for the last four days of the study break. We analyzed the participants' wrist actigraphy data during these four days to examine intraindividual variability in sleep timing, duration and efficiency. We also examined shifts in the DLMO from before and after the study break. RESULTS AND CONCLUSIONS: Under the same conditions, people with DSWPD had significantly more variable wake times and total sleep time than healthy controls (p ≤ 0.015). Intraindividual variability in sleep onset time and sleep efficiency was similar between the two groups (p ≥ 0.30). The DLMO was relatively stable across the study break, with only 11% of controls but 27% of DSWPDs showed more than a one hour shift in the DLMO. Only in the DSWPD sample was greater sleep variability associated with a larger shift in the DLMO (r = 0.46, p = 0.03). These results suggest that intraindividual variability in sleep can be higher in DSWPD versus healthy controls, and this may impact variability in the DLMO. DSWPD patients with higher intraindividual variability in sleep are more likely to have a shifting DLMO, which could impact sleep symptoms and the optimal timing of light and/or melatonin treatment for DSWPD. CLINICAL TRIAL: Circadian Phase Assessments at Home, http://clinicaltrials.gov/show/NCT01487252, NCT01487252.
Authors: Richard P Allen; Daniel L Picchietti; Diego Garcia-Borreguero; William G Ondo; Arthur S Walters; John W Winkelman; Marco Zucconi; Raffaele Ferri; Claudia Trenkwalder; Hochang B Lee Journal: Sleep Med Date: 2014-05-17 Impact factor: 3.492
Authors: Gorica Micic; Nicole Lovato; Michael Gradisar; Sally A Ferguson; Helen J Burgess; Leon C Lack Journal: Sleep Med Rev Date: 2015-07-03 Impact factor: 11.609
Authors: Helen J Burgess; Victoria L Revell; Thomas A Molina; Charmane I Eastman Journal: J Clin Endocrinol Metab Date: 2010-04-21 Impact factor: 5.958
Authors: Lauren A Watson; Elise M McGlashan; Ihaia T Hosken; Clare Anderson; Andrew J K Phillips; Sean W Cain Journal: J Clin Sleep Med Date: 2020-09-15 Impact factor: 4.062
Authors: Andrew W McHill; Akane Sano; Cassie J Hilditch; Laura K Barger; Charles A Czeisler; Rosalind Picard; Elizabeth B Klerman Journal: J Pineal Res Date: 2021-02-16 Impact factor: 12.081